Summary:
To study the safety and effectiveness of a new medication to relieve the symptoms of burning urination associated with urinary tract infections (UTI). Study duration is 4 days with 2 clinic visits.
Qualified Participants Must:
• Be female and between 18 and 75 years of age
•
Have symptoms of a UTI and have it positively diagnosed in our office with a dipstick test leukocyte esterace
Qualified Participants May Receive:
One of three possible dosages of study medication or a placebo, antibiotic treatment,
compensation of $150 for participation.